Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Todos Medical Ltd TOMDF

Todos Medical Ltd is a Israel-based clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer. The Companys Total Biochemical Infrared Analysis (TBIA) platform, represents a method for cancer screening of solid tumors using peripheral blood spectroscopy analysis. The process involves observing the immune system’s response to tumor... see more

Recent & Breaking News (GREY:TOMDF)

Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies

GlobeNewswire January 18, 2022

Todos Medical to Announce Topline Results from Tollovir(TM) Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022

GlobeNewswire January 12, 2022

Todos Medical CEO to Appear on Fox Business to Talk COVID Testing & Tollovir on Tuesday, January 11, 2022 and is Presenting at Biotech Showcase 2022

GlobeNewswire January 10, 2022

Todos Medical CEO Provides Letter to Shareholders

GlobeNewswire January 5, 2022

Todos Medical to Present at January 5, 2022 Emerging Growth Conference

GlobeNewswire January 3, 2022

Todos Medical Records Record Weekly COVID PCR Testing Volumes at Provista

GlobeNewswire December 27, 2021

Todos Medical CEO to Appear on Yahoo Finance Live! at 12:10PM EST with Akiko Fujita to Talk Pfizer's Paxlovid Approval, Tollovir(TM) Phase 2 & COVID Testing

GlobeNewswire December 23, 2021

Todos Medical Announces New cPass Neutralizing Antibody Testing Reference Lab Agreement for CLIA/CAP Lab Provista with Physician Group in 40 States

GlobeNewswire December 22, 2021

Todos Medical Appoints Valentino Smith, MBA as Vice President of Marketing

GlobeNewswire December 20, 2021

Todos Medical Announces "Test & Tollovid®" Holiday Package for Atlanta Area at Provista Diagnostics

GlobeNewswire December 17, 2021

Todos Medical to Host Key Opinion Leader Webinar Entitled Tollovir(TM): a Potential Treatment for Covid-19

GlobeNewswire December 16, 2021

Todos Medical Enters 90-Day Extension of Agreement with Convertible Note Holders on Moratorium on Conversions of Convertible Notes

GlobeNewswire December 13, 2021

Todos Medical Interview and Presentation on Benzinga's All Access Conference Live December 14th at 10:20 AM EST

GlobeNewswire December 10, 2021

Todos Medical Announces 2 New COVID-19 PCR Testing Reference Lab Agreements for CLIA/CAP Lab Provista Diagnostics

GlobeNewswire December 7, 2021

Todos Medical to Present at Upcoming Emerging Growth Conference

GlobeNewswire December 6, 2021

Todos Medical Announces All 31 Patients Enrolled to Date in Tollovir® Phase 2 Clinical Trial in Hospitalized COVID-19 Patients Have Completed Study Participation

GlobeNewswire December 2, 2021

Todos Medical to Host Business Update Conference Call on December 2nd at 4:30 PM EST

GlobeNewswire December 1, 2021

Todos Medical Confirms SARS-CoV-2 PCR Test Kits Used at CLIA/CAP Lab Provista Diagnostics Detect Omicron Variant

GlobeNewswire November 30, 2021

Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma

GlobeNewswire November 29, 2021

Todos Medical Receives Purchase Order for 50,000 Bottles of Tollovid Daily from Its European Distribution Partner T-Cell Protect Hellas S.A for Initial Market Launch in Greece

GlobeNewswire November 22, 2021